Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812539 · ClinicalTrials.gov registry record · NA
Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 Diabetes
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00812539: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00812539 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00812539, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Currently, diabetic patients who receive their care at the diabetes clinic self monitor their blood glucose using a portable glucometer, under the direction of care providers at the clinic. We propose to conduct a randomized controlled trial to examine the effect of the "Diabetes Connected Health" tool, which is a secure website shared between patients of Type-2 Diabetes and their providers and displays (subjects') blood glucose values in graphical format. The study will be carried out through multiple primary care practices within the Partners/PCHI Network. We hypothesize that implementation of the Diabetes Connected Health Tool will result in overall better Diabetes Care, in terms of improved patient-provider interaction, and better patient satisfaction towards their care.
Interventions
- OTHER Subject/Provider Portal "Diabetes Connected Health" tool - Deluxe
- OTHER Subject only Portal "Diabetes Connected Health Tool" Basic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812539
The ClinicalTrials.gov registry entry for NCT00812539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Subject/Provider Portal "Diabetes Connected Health" tool - Deluxe is the first listed.
NCT00812539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812539 about?
NCT00812539 is a clinical study titled "Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 Diabetes". Currently, diabetic patients who receive their care at the diabetes clinic self monitor their blood glucose using a portable glucometer, under the direction of care providers at the clinic. We propose to conduct a randomized controlled trial to examine the effect of the "Diabetes Connected Health" t...
What is the current status of trial NCT00812539?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-02. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00812539?
The interventions under investigation include: Subject/Provider Portal "Diabetes Connected Health" tool - Deluxe (OTHER), Subject only Portal "Diabetes Connected Health Tool" Basic (OTHER).
Who is sponsoring clinical trial NCT00812539?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.